| Primary |
| Multiple Sclerosis |
90.4% |
| Drug Use For Unknown Indication |
2.6% |
| Pain |
1.2% |
| Migraine Prophylaxis |
0.7% |
| Depression |
0.6% |
| Osteoporosis |
0.5% |
| Affective Disorder |
0.4% |
| Anxiety |
0.4% |
| Contraception |
0.4% |
| Routine Health Maintenance |
0.4% |
| Constipation |
0.3% |
| Vaginitis Bacterial |
0.3% |
| Epilepsy |
0.3% |
| Neurogenic Bladder |
0.2% |
| Tremor |
0.2% |
| Back Pain |
0.2% |
| Crohn's Disease |
0.2% |
| Hypertension |
0.2% |
| Muscle Spasticity |
0.2% |
| Relapsing-remitting Multiple Sclerosis |
0.2% |
|
| Urinary Tract Infection |
16.7% |
| Progressive Multifocal Leukoencephalopathy |
13.9% |
| Vomiting |
8.7% |
| Multiple Sclerosis |
7.0% |
| Thrombosis |
6.1% |
| White Blood Cell Count Increased |
5.9% |
| Convulsion |
5.2% |
| White Blood Cell Count Decreased |
3.5% |
| Urosepsis |
3.3% |
| Urticaria |
3.3% |
| Pain |
3.1% |
| Syncope |
3.1% |
| Breast Cancer Female |
2.8% |
| Myocardial Infarction |
2.8% |
| Pyrexia |
2.6% |
| Weight Decreased |
2.6% |
| Pain In Extremity |
2.4% |
| Upper Respiratory Tract Infection |
2.4% |
| Malignant Melanoma |
2.2% |
| Pneumonia |
2.2% |
|
| Secondary |
| Multiple Sclerosis |
80.0% |
| Product Used For Unknown Indication |
8.3% |
| Crohn's Disease |
4.9% |
| Drug Use For Unknown Indication |
2.0% |
| Relapsing-remitting Multiple Sclerosis |
1.5% |
| Back Pain |
0.8% |
| Hypertension |
0.8% |
| Type 2 Diabetes Mellitus |
0.5% |
| Blood Oestrogen |
0.2% |
| Fatigue |
0.2% |
| Gait Disturbance |
0.2% |
| Hypersomnia |
0.2% |
| Pain |
0.2% |
| Sepsis |
0.2% |
|
| Infusion Related Reaction |
8.8% |
| Urticaria |
8.8% |
| Vomiting |
7.7% |
| Completed Suicide |
6.6% |
| Muscle Spasticity |
6.6% |
| Urinary Tract Infection |
6.6% |
| Malignant Melanoma |
5.5% |
| Salivary Gland Cancer |
5.5% |
| Drug Ineffective |
4.4% |
| Pain In Extremity |
4.4% |
| Patella Fracture |
4.4% |
| Syncope |
4.4% |
| Keratitis |
3.3% |
| Large Intestine Perforation |
3.3% |
| Pain |
3.3% |
| Pancreatitis |
3.3% |
| Progressive Multifocal Leukoencephalopathy |
3.3% |
| Rash |
3.3% |
| Skin Cancer |
3.3% |
| Skin Reaction |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.0% |
| Drug Use For Unknown Indication |
21.0% |
| Crohn's Disease |
12.0% |
| Headache |
8.5% |
| Multiple Sclerosis |
8.0% |
| Pain |
5.5% |
| Hypertension |
4.5% |
| Smoking Cessation Therapy |
4.5% |
| Relapsing-remitting Multiple Sclerosis |
3.0% |
| Drug Ineffective |
2.0% |
| Prophylaxis |
2.0% |
| Neuropathy Peripheral |
1.5% |
| Fatigue |
1.0% |
| Migraine |
1.0% |
| Osteoporosis |
1.0% |
| Anaemia |
0.5% |
| Depression |
0.5% |
| Gait Disturbance |
0.5% |
| Joint Ankylosis |
0.5% |
| Muscle Spasms |
0.5% |
|
| Heart Rate Decreased |
17.2% |
| Off Label Use |
6.9% |
| Pain |
6.9% |
| Prinzmetal Angina |
6.9% |
| Respiratory Disorder |
6.9% |
| Tremor |
6.9% |
| Aggression |
3.4% |
| Back Pain |
3.4% |
| Benign Neoplasm Of Thyroid Gland |
3.4% |
| Blister |
3.4% |
| Blood Immunoglobulin G Decreased |
3.4% |
| Bone Pain |
3.4% |
| Cardio-respiratory Arrest |
3.4% |
| Completed Suicide |
3.4% |
| Convulsion |
3.4% |
| Drug Ineffective |
3.4% |
| Hypersensitivity |
3.4% |
| Hypertension |
3.4% |
| Incisional Hernia |
3.4% |
| Injection Site Haemorrhage |
3.4% |
|
